Kiyoshi Mizuguchi Selected Research

M55551

1/2006

Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Mizuguchi Research Topics

Disease

3	Endometriosis 02/2012 - 10/2009
3	Inflammation (Inflammations) 12/2011 - 03/2010
3	Alzheimer Disease (Alzheimer's Disease) 04/2010 - 07/2008
2	Fibrosis (Cirrhosis) 04/2011 - 03/2010
2	Nervous System Diseases (Neurological Disorders) 04/2010 - 07/2008
2	Hypertriglyceridemia 03/2010 - 04/2009
2	Asthma (Bronchial Asthma) 01/2005 - 07/2003
1	Coronary Disease (Coronary Heart Disease) 12/2011
1	IGA Glomerulonephritis (IGA Nephropathy) 11/2011
1	Nephritis 11/2011
1	Hyperlipidemias (Hyperlipidemia) 04/2011
1	Uterine Diseases (Endometrial Disease) 01/2011
1	Hyperinsulinism (Hyperinsulinemia) 10/2010
1	Obesity 10/2010
1	Body Weight (Weight, Body) 10/2010
1	Hyperglycemia 10/2010
1	Huntington Disease (Huntington's Disease) 04/2010
1	Schizophrenia (Dementia Praecox) 04/2010
1	Non-alcoholic Fatty Liver Disease 03/2010
1	Cognitive Dysfunction 12/2009
1	Hepatitis 04/2009
1	Glioma (Gliomas) 07/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2008
1	Hemorrhage 01/2006
1	Thrombosis (Thrombus) 01/2006
1	Neoplasms (Cancer) 01/2005
1	Disease Progression 01/2005
1	Atopic Dermatitis (Atopic Eczema) 01/2005
1	Splenomegaly 01/2005
1	Melanoma (Melanoma, Malignant) 01/2005
1	Atherosclerotic Plaque (Atheroma) 01/2002

Drug/Important Bio-Agent (IBA)

7	Eicosapentaenoic AcidIBA 11/2011 - 07/2008
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2011 - 07/2008
3	Triglycerides (Triacylglycerol)IBA 12/2011 - 10/2010
2	Therapeutic UsesIBA 02/2012 - 01/2011
2	Prostaglandins EIBA 02/2012 - 01/2011
2	Aromatase (CYP19)IBA 02/2012 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2011 - 03/2010
2	dienogest FDA Link 01/2011 - 10/2009
2	Sucrose (Saccharose)IBA 10/2010 - 04/2009
2	M 50367IBA 01/2005 - 07/2003
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 12/2011
1	VLDL LipoproteinsIBA 12/2011
1	NF-kappa B (NF-kB)IBA 11/2011
1	Docosahexaenoic AcidsIBA 11/2011
1	Fish OilsIBA 11/2011
1	Methionine (L-Methionine)FDA Link 04/2011
1	Choline (Choline Chloride)IBA 04/2011
1	EstersIBA 04/2011
1	ProstaglandinsIBA 01/2011
1	EnzymesIBA 10/2010
1	Hydroxyproline (4 Hydroxyproline)IBA 03/2010
1	eicosapentaenoic acid ethyl esterIBA 03/2010
1	Peptides (Polypeptides)IBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	Amyloid beta-PeptidesIBA 12/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2009
1	GalactosamineIBA 04/2009
1	InterleukinsIBA 07/2008
1	PPAR gammaIBA 07/2008
1	LigandsIBA 07/2008
1	Interleukin-6 (Interleukin 6)IBA 07/2008
1	CytokinesIBA 07/2008
1	Warfarin (Coumadin)FDA LinkGeneric 01/2006
1	M55165IBA 01/2006
1	M55551IBA 01/2006
1	argatroban (MPQA)FDA Link 01/2006
1	Factor Xa InhibitorsIBA 01/2006
1	Picryl Chloride (Trinitrochlorobenzene)IBA 01/2005
1	Interferon-gamma (Interferon, gamma)IBA 01/2005
1	Immunoglobulin E (IgE)IBA 01/2005
1	Anti-Allergic Agents (Antiallergic Agents)IBA 07/2003
1	CholesterolIBA 01/2002
1	AcidsIBA 01/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 03/2010
1	Oral Administration 01/2006
1	Intravenous Administration 01/2006
1	Immunomodulation 01/2005